BrP-LPA

Overview

BrP-LPA is a LPA antagonist/ ATX inhibitor. BrP-LPA shows pan-antagonist activity towards LPA 1-4 GPCRs. BrP-LPA decreases blood vessel density. BrP-LPA dose-dependently inhibits Lysophosphatidic acid-induced head-dip counts. BrP-LPA exhibits anticancer activity against breast cancer , colon cancer , and lung cancer . BrP-LPA inhibits anxiety-like behavior.

Application

Products | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Anxiety or Fear-Related Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > LPL Receptor | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-W725737
• CAS No.: 944313-05-7
• Molecular Formula: C20H40BrO6P
• Molecular Weight: 487.41
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source